Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo

Integrase (IN), the HIV-1 enzyme responsible for the integration of the viral genome into the chromosomes of infected cells, is the target of the recently approved antiviral raltegravir (RAL). Despite this drug's activity against viruses resistant to other antiretrovirals, failures of raltegrav...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Delelis, Olivier, Thierry, Sylvain, Subra, Frédéric, Simon, Françoise, Malet, Isabelle, Alloui, Chakib, Sayon, Sophie, Calvez, Vincent, Deprez, Eric, Marcelin, Anne-Geneviève, Tchertanov, Luba, Mouscadet, Jean-François
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2010
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798554/
https://ncbi.nlm.nih.gov/pubmed/19901095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01075-09
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items